Back to User profile » Dr Alejandro García-Carrancá

Papers published by Dr Alejandro García-Carrancá:

Corrigendum

Antimetastatic Effect of Epigenetic Drugs, Hydralazine and Valproic Acid, in Ras-Transformed NIH 3T3 Cells [Corrigendum]

Pérez-Cárdenas E, Taja-Chayeb L, Trejo-Becerril C, Chanona-Vilchis J, Chávez-Blanco A, Domínguez-Gómez G, Langley E, García-Carrancá A, Dueñas-González A

OncoTargets and Therapy 2022, 15:845-846

Published Date: 4 August 2022

Original Research

Progesterone Receptor Together with PKCα Expression as Prognostic Factors for Astrocytomas Malignancy

Arcos-Montoya D, Wegman-Ostrosky T, Mejía-Pérez S, De la Fuente-Granada M, Camacho-Arroyo I, García-Carrancá A, Velasco-Velázquez MA, Manjarrez-Marmolejo J, González-Arenas A

OncoTargets and Therapy 2021, 14:3757-3768

Published Date: 16 June 2021

Original Research

Antimetastatic effect of epigenetic drugs, hydralazine and valproic acid, in Ras-transformed NIH 3T3 cells

Pérez-Cárdenas E, Taja-Chayeb L, Trejo-Becerril C, Chanona-Vilchis J, Chávez-Blanco A, Domínguez-Gómez G, Langley E, García-Carrancá A, Dueñas-González A

OncoTargets and Therapy 2018, 11:8823-8833

Published Date: 7 December 2018